Download Citation
Article Source:
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design
Viegas EO,
Kroidl A,
Munseri PJ,
Missanga M,
Nilsson C,
et al.
(2018)
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
PLOS ONE 13(11): e0206838.
https://doi.org/10.1371/journal.pone.0206838